Skip to main content

Table 2 Independent risk factors influencing PGLYRP2 level

From: PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus

Subject β SE β’ t P β (95%CI)
Lower Upper
Constant 4872.328 534.883   9.109 0.000 3768.383 5976.273
SLEDAI 57.199 18.537 0.716 3.086 0.005 18.940 95.459
C3 −1.224 44.267 −0.010 −0.028 0.978 −92.585 90.138
C4 −290.858 1318.002 − 0.073 − 0.221 0.827 − 3011.081 2429.365
GFR −1.962 3.365 −0.113 −0.583 0.565 −8.908 4.983
24 h urine protein 0.026 0.034 0.124 0.775 0.446 −0.043 0.096
IgA −45.934 69.554 −0.117 −0.660 0.515 − 189.487 97.618
HDLC −69.796 194.271 −0.076 −0.359 0.723 − 470.750 331.159
APOA1 −109.037 396.500 −0.061 −0.275 0.786 − 927.372 709.298
apo-B/A1 −41.092 181.885 −0.054 −0.226 0.823 −416.484 334.300
  1. β, beta coefficient; SE, standard error; β’, standardized beta coefficient; β (95%CI), 95% confidence interval of beta coefficient